novo nordisk reuters - Search News

News

Novo Nordisk, Wegovy

Reuters on MSN · 2d

Novo Nordisk hopes to see US Wegovy sales recover soon

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound copycats is enforced this month, its CEO said on Wednesday after the company cut its 2025 forecasts.

Seeking Alpha on MSN · 2d

Novo Nordisk cuts 2025 outlook. But why are its shares rising?

With its Q1 2025 results on Wednesday, Novo Nordisk (NVO) lowered its full-year outlook, but its shares were rising in European trading after the pharma giant projected a sales recovery for its blockbuster weight loss therapy Wegovy in the months ahead.

CNBC on MSN · 2d

It's going to be 'put up or shut up' for Novo Nordisk's Wegovy this summer: Barclays' Emily Field

Emily Field, Barclacys head of European pharmaceuticals equity research, joins 'Squawk Box' to discuss Novo Nordisk's quarterly earnings results, impact of copycat compounded drugs on Wegovy sales, state of the obesity drug competition,

2don MSN

Novo Nordisk latest drugmaker to drop gender goals in US

Obesity drugmaker Novo Nordisk said on Wednesday it would drop gender representation requirements for senior leadership ...

8don MSN

Why Novo Nordisk Stock Popped Today

Novo Nordisk ( NVO 0.33%) stock jumped 3.1% at the open Thursday morning before drifting back. As of 10:54 a.m. ET, it was ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results